Massari F.; Di Nunno V.; Guida A.; Costa Silva C.A.; Derosa L.; Mollica V.; Colomba E.; Brandi G.; Albiges L., Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study, «CLINICAL GENITOURINARY CANCER», 2021, 19, pp. 32 - 40 [articolo]
Massari, Francesco; Di Nunno, Vincenzo; Guida, Annalisa; Costa Silva, Carolina Alves; Derosa, Lisa; Mollica, Veronica; Colomba, Emeline; Brandi, Giovanni; Albiges, Laurence, Addition of Primary Metastatic Site on Bone, Brain, and Liver to IMDC Criteria in Patients With Metastatic Renal Cell Carcinoma: A Validation Study, «CLINICAL GENITOURINARY CANCER», 2021, 19, pp. 32 - 40 [articolo]
Rizzo A.; Brandi G., Adjuvant systemic treatment in resected biliary tract cancer: State of the art, controversies, and future directions, «CANCER TREATMENT AND RESEARCH COMMUNICATIONS», 2021, 27, Article number: 100334, pp. 1 - 7 [articolo]Open Access
Munoz-Martinez S.; Sapena V.; Forner A.; Nault J.-C.; Sapisochin G.; Rimassa L.; Sangro B.; Bruix J.; Sanduzzi-Zamparelli M.; Holowko W.; El Kassas M.; Mocan T.; Bouattour M.; Merle P.; Hoogwater F.J.H.; Alqahtani S.A.; Reeves H.L.; Pinato D.J.; Giorgakis E.; Meyer T.; Villadsen G.E.; Wege H.; Salati M.; Minguez B.; Di Costanzo G.G.; Roderburg C.; Tacke F.; Varela M.; Galle P.R.; Alvares-da-Silva M.R.; Trojan J.; Bridgewater J.; Cabibbo G.; Toso C.; Lachenmayer A.; Casadei-Gardini A.; Toyoda H.; Ludde T.; Villani R.; Matilla Pena A.M.; Guedes Leal C.R.; Ronzoni M.; Delgado M.; Perello C.; Pascual S.; Lledo J.L.; Argemi J.; Basu B.; da Fonseca L.; Acevedo J.; Siebenhuner A.R.; Braconi C.; Meyers B.M.; Granito A.; Sala M.; Rodriguez-Lope C.; Blaise L.; Romero-Gomez M.; Pinero F.; Gomez D.; Mello V.; Pinheiro Alves R.C.; Franca A.; Branco F.; Brandi G.; Pereira G.; Coll S.; Guarino M.; Benitez C.; Anders M.M.; Bandi J.C.; Vergara M.; Calvo M.; Peck-Radosavljevic M.; Garcia-Juarez I.; Cardinale V.; Lozano M.; Gambato M.; Okolicsanyi S.; Morales-Arraez D.; Elvevi A.; Munoz A.E.; Lue A.; Iavarone M.; Reig M., Assessing the impact of COVID-19 on liver cancer management (CERO-19), «JHEP REPORTS», 2021, 3, pp. 1 - 9 [articolo]Open Access
Rizzo A.; Ricci A.D.; Brandi G., Atezolizumab in advanced hepatocellular carcinoma: Good things come to those who wait, «IMMUNOTHERAPY», 2021, 13, pp. 637 - 644 [articolo]
Marinaccio A.; Consonni D.; Mensi C.; Mirabelli D.; Migliore E.; Magnani C.; Di Marzio D.; Gennaro V.; Mazzoleni G.; Girardi P.; Negro C.; Romanelli A.; Chellini E.; Grappasonni I.; Madeo G.; Romeo E.; Ascoli V.; Carrozza F.; Angelillo I.F.; Cavone D.; Tumino R.; Melis M.; Curti S.; Brandi G.; Mattioli S.; Iavicoli S., Authors’ response: Mezei et al's "comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis", «SCANDINAVIAN JOURNAL OF WORK, ENVIRONMENT & HEALTH», 2021, 47, pp. 87 - 89 [replica/breve intervento]
Rizzo A.; Ricci A.D.; Brandi G., Bayesian Analysis Supports Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma, «LIVER CANCER», 2021, 1, pp. 1 - 2 [articolo]
Rizzo A.; Brandi G., BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 483 - 485 [replica/breve intervento]
Rizzo A.; Brandi G., Biochemical predictors of response to immune checkpoint inhibitors in unresectable hepatocellular carcinoma, «CANCER TREATMENT AND RESEARCH COMMUNICATIONS», 2021, 27, Article number: 100328, pp. 100328 - 100334 [articolo]Open Access
Filippi R.; Leone F.; Fornaro L.; Aprile G.; Casadei-Gardini A.; Silvestris N.; Palloni A.; Satolli M.A.; Scartozzi M.; Russano M.; Lutrino S.E.; Lombardi P.; Frega G.; Garattini S.K.; Vivaldi C.; Spadi R.; Giulia O.; Fenocchio E.; Brunetti O.; Aglietta M.; Brandi G., Clinical insights and prognostic factors from an advanced biliary tract cancer case series: a real-world analysis, «JOURNAL OF CHEMOTHERAPY», 2021, 1, pp. 1 - 10 [articolo]
Rizzo A.; Ricci A.D.; Brandi G., Combination therapy of dabrafenib plus trametinib in patients with BRAFV600E-mutated biliary tract cancer, «HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL», 2021, 20, pp. 506 - 507 [replica/breve intervento]
Filippini D.M.; Di Federico A.; Lenzi B.; Nobili E.; Brocchi S.; Malvi D.; Brandi G., Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report, «ANNALS OF PALLIATIVE MEDICINE», 2021, 10, pp. 8474 - 8478 [articolo]Open Access
Rizzo A.; Ricci A.D.; Brandi G., Detecting and targeting NTRK gene fusions in cholangiocarcinoma: news and perspectives, «EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT», 2021, 6, pp. 225 - 227 [articolo]
Ricci A.D.; Rizzo A.; Brandi G., DNA damage response alterations in gastric cancer: Knocking down a new wall, «FUTURE ONCOLOGY», 2021, 17, pp. 865 - 868 [articolo]
Rizzo A.; Ricci A.D.; Brandi G., Durvalumab: an investigational anti-PD-L1 antibody for the treatment of biliary tract cancer, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 343 - 350 [articolo]
